Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications

Fig. 4

Combined models for ABx and CS and controlling for covariates. a Kaplan-Meier curves for ABx and CS in combination. b Cox Proportional Hazards model incorporating both ABx and CS as well as several covariates. c Cox-LASSO models for each cancer showing the hazard ratios estimated for covariates and the number of times the covariate was included in the model. The regularization parameter was selection by 10-fold cross validation, and then the robustness was assessed by 1000 bootstrap replicates using different random samples of the data

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us